SEARCH RESULTS
News
The guidelines will help clinicians to assess and manage the sexual side effects of prostate cancer.
Your donations in 2024 funded Movember's work across men's mental health and suicide prevention, prostate cancer and testicular cancer.
The QScale team is fundraising and having fun at work this Movember
Content creator Jon Gustin, aka. The Tired Dad shares his hopes for the next generation of dads, what he loves most about fatherhood, and his tips for raising the next generation of men.
New research findings from a Movember-funded clinical trial called ENZA-p reveals a world-first combination treatment approach that has led to longer and better-quality lives for men living with incurable prostate cancer.
In 2024, Movember made a landmark commitment: CAN$52.69 million over seven years to improve the social and emotional wellbeing of Indigenous men and boys across Australia, Aotearoa New Zealand, Canada, and the United States. In 2025, we’re delivering on that promise — announcing the first round of Innovation Grants, supporting Indigenous-led solutions that are rooted in culture, community, and self-determination.
A new project aims to speed up prostate cancer clinical trials and get new cancer treatments sooner to men.
The FDA approval raises hopes that this prostate cancer treatment will be approved in other parts of the world, making it available to more men.
A ground-breaking trial supported by Movember has shown that combining two different drugs could delay the progression of advanced prostate cancer by an average of five months.
Movember funding has supported ground-breaking new research which harnesses the use of artificial intelligence to improve prostate cancer treatment.
The IRONMAN EMPRO sub-study is a Movember funded prostate cancer research study to improve care and quality of life for men
